Concepedia

Cong Xu

CX

Statistics

Publications

12

Citations

624

H-Index

12

Active since

2004

Affiliations

University of Washington(Current)

Indiana University School of Medicine

Indiana University – Purdue University Indianapolis

Frederick National Laboratory for Cancer Research

Stella Therapeutics (United States)

Cong Xu is an author at University of Washington specializing in pharmacology, medicine, and cytochrome p450 enzymes.

ORCID

Publications per year

2004–2022

12

Publications

12

Identification of a Novel Endocannabinoid-Hydrolyzing Enzyme Expressed by Microglial Cells

Giulio G. Muccioli, Cong Xu, Emma Odah et al. · Journal of Neuroscience · 2007 · 172 citations · Full text

, , +13

Enantiomers of naringenin as pleiotropic, stereoselective inhibitors of cytochrome P450 isoforms

Wenjie Lu, Valentina Ferlito, Cong Xu et al. · Chirality · 2011 · 78 citations

, , +17

The tamoxifen metabolite norendoxifen is a potent and selective inhibitor of aromatase (CYP19) and a potential lead compound for novel therapeutic agents

Wenjie Lu, Cong Xu, Zifan Pei et al. · Breast Cancer Research and Treatment · 2011 · 73 citations

, , +17

Effects of the CYP2B6*6 Allele on Catalytic Properties and Inhibition of CYP2B6 In Vitro: Implication for the Mechanism of Reduced Efavirenz Metabolism and Other CYP2B6 Substrates In Vivo

Cong Xu, Evan T. Ogburn, Yingying Guo et al. · Drug Metabolism and Disposition · 2012 · 68 citations · Full text

, , +16

In Vitro Analysis and Quantitative Prediction of Efavirenz Inhibition of Eight Cytochrome P450 (CYP) Enzymes: Major Effects on CYPs 2B6, 2C8, 2C9 and 2C19

Cong Xu, Zeruesenay Desta · Drug Metabolism and Pharmacokinetics · 2013 · 54 citations · Full text

, , +17

1–5 of 12